NEVVI Medicare utilization intelligence
or

← back

Provider profile

COHEN, STEVEN M.D.

Dermatology · NPI 1235124355 · NEW YORK, NY

1
Groups
14
Codes · 2024
1,278
Disclosed services

COHEN, STEVEN is a Dermatology in NEW YORK, NY, a member of 1 medical group, who billed 14 distinct codes to Medicare Part B in 2024.

Groups: WEILL MEDICAL COLLEGE OF CORNELL (NEW YORK, NY)

Year: 2024 · 2023 · 2022 🔒 · 2021 🔒 · 2020 🔒

Provider overview · all codes · CY2024

1,278
disclosed services
14
codes billed to Medicare Part B
Prior year · CY2023 403 disclosed services

This provider's disclosed Medicare payments across all codes were in CY2024.

Dollars, place-of-service mix, business mix and national standing are part of the market analytics platform — built, not launched yet. Notify me at launch →

All figures are disclosed (CMS suppresses fewer-than-11-beneficiary rows) Medicare Part B fee-for-service — a subset, never complete totals; volumes are personal to this NPI, not attributed to any group. Standing is a billed-volume position among specialty peers with disclosed billing (national percentile; a provider's true standing can only be higher, never lower), not a statement about care. See Methods & Sources.

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
This provider's Medicare volumes — services, beneficiary-episodes, and charges — are part of the market analytics platform — built, not launched yet. Notify me at launch →
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
17003 Destruction of precancer skin growth, 2-14 growths
36415 Insertion of needle into vein for collection of blood sample
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
11102 Biopsy of related skin growth, first growth
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
17000 Destruction of precancer skin growth, 1 growth
99203 New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
96372 Injection of drug or substance under skin or into muscle
11901 Injection into skin growth, more than 7 growths
11103 Biopsy of related skin growth, each additional growth

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.